Skip to Content

VolitionRX Ltd VNRX

Morningstar Rating
$0.96 +0.01 (0.79%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VNRX is trading at a 40% discount.
Price
$1.03
Fair Value
$2.39
Uncertainty
Extreme
1-Star Price
$27.94
5-Star Price
$8.44
Economic Moat
Ftqy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VNRX is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.96
Day Range
$0.961.02
52-Week Range
$0.562.08
Bid/Ask
$0.95 / $1.01
Market Cap
$75.83 Mil
Volume/Avg
82,627 / 247,074

Key Statistics

Price/Earnings (Normalized)
Price/Sales
108.09
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

VolitionRX Ltd is a United states based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Growth
Total Number of Employees
104

Comparables

Valuation

Metric
VNRX
TIHE
4671
Price/Earnings (Normalized)
16.98
Price/Book Value
0.95
Price/Sales
108.090.58
Price/Cash Flow
14.51
Price/Earnings
VNRX
TIHE
4671

Financial Strength

Metric
VNRX
TIHE
4671
Quick Ratio
0.611.89
Current Ratio
0.692.30
Interest Coverage
−154.61268.64
Quick Ratio
VNRX
TIHE
4671

Profitability

Metric
VNRX
TIHE
4671
Return on Assets (Normalized)
−150.39%5.79%
Return on Equity (Normalized)
−7,236.93%8.44%
Return on Invested Capital (Normalized)
−711.91%7.75%
Return on Assets
VNRX
TIHE
4671
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncFdvhx$215.3 Bil
DHR
Danaher CorpZfdttd$187.8 Bil
IDXX
IDEXX Laboratories IncPbvblx$47.9 Bil
IQV
IQVIA Holdings IncFhzqgv$45.0 Bil
A
Agilent Technologies IncWxbwy$38.7 Bil
MTD
Mettler-Toledo International IncKhjknp$26.0 Bil
ICLR
Icon PLCBghykd$25.9 Bil
ILMN
Illumina IncQtpcg$21.1 Bil
WAT
Waters CorpFynbw$19.6 Bil
LH
Laboratory Corp of America HoldingsRfzgdt$18.4 Bil

Sponsor Center